These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

573 related items for PubMed ID: 21883949

  • 1. Satisfying sexual events as outcome measures in clinical trial of female sexual dysfunction.
    Kingsberg SA, Althof SE.
    J Sex Med; 2011 Dec; 8(12):3262-70. PubMed ID: 21883949
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder.
    Kingsberg S, Shifren J, Wekselman K, Rodenberg C, Koochaki P, Derogatis L.
    J Sex Med; 2007 Jul; 4(4 Pt 1):1001-8. PubMed ID: 17627745
    [Abstract] [Full Text] [Related]

  • 3. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET Study.
    Derogatis LR, Komer L, Katz M, Moreau M, Kimura T, Garcia M, Wunderlich G, Pyke R, VIOLET Trial Investigators.
    J Sex Med; 2012 Apr; 9(4):1074-85. PubMed ID: 22248038
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial.
    Katz M, DeRogatis LR, Ackerman R, Hedges P, Lesko L, Garcia M, Sand M, BEGONIA trial investigators.
    J Sex Med; 2013 Jul; 10(7):1807-15. PubMed ID: 23672269
    [Abstract] [Full Text] [Related]

  • 5. Flibanserin for Premenopausal Hypoactive Sexual Desire Disorder: Pooled Analysis of Clinical Trials.
    Simon JA, Thorp J, Millheiser L.
    J Womens Health (Larchmt); 2019 Jun; 28(6):769-777. PubMed ID: 30707049
    [Abstract] [Full Text] [Related]

  • 6. Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): results from a randomized withdrawal trial.
    Goldfischer ER, Breaux J, Katz M, Kaufman J, Smith WB, Kimura T, Sand M, Pyke R.
    J Sex Med; 2011 Nov; 8(11):3160-72. PubMed ID: 21933348
    [Abstract] [Full Text] [Related]

  • 7. The current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
    Kingsberg SA, Simon JA, Goldstein I.
    J Sex Med; 2008 Sep 02; 5 Suppl 4():182-93; quiz 193. PubMed ID: 18783534
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy and Safety of Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Women: A Systematic Review and Meta-analysis.
    Jaspers L, Feys F, Bramer WM, Franco OH, Leusink P, Laan ET.
    JAMA Intern Med; 2016 Apr 02; 176(4):453-62. PubMed ID: 26927498
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Validation of the female sexual distress scale-revised for assessing distress in women with hypoactive sexual desire disorder.
    Derogatis L, Clayton A, Lewis-D'Agostino D, Wunderlich G, Fu Y.
    J Sex Med; 2008 Feb 02; 5(2):357-64. PubMed ID: 18042215
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder.
    Simon J, Braunstein G, Nachtigall L, Utian W, Katz M, Miller S, Waldbaum A, Bouchard C, Derzko C, Buch A, Rodenberg C, Lucas J, Davis S.
    J Clin Endocrinol Metab; 2005 Sep 02; 90(9):5226-33. PubMed ID: 16014407
    [Abstract] [Full Text] [Related]

  • 15. Validation of a Women's Sexual Interest Diagnostic Interview--Short Form (WSID-SF) and a Daily Log of Sexual Activities (DLSA) in postmenopausal women with hypoactive sexual desire disorder.
    DeRogatis LR, Allgood A, Auerbach P, Eubank D, Greist J, Bharmal M, Zipfel L, Guo CY.
    J Sex Med; 2010 Feb 02; 7(2 Pt 2):917-27. PubMed ID: 19832932
    [Abstract] [Full Text] [Related]

  • 16. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the DAISY study.
    Thorp J, Simon J, Dattani D, Taylor L, Kimura T, Garcia M, Lesko L, Pyke R, DAISY trial investigators.
    J Sex Med; 2012 Mar 02; 9(3):793-804. PubMed ID: 22239862
    [Abstract] [Full Text] [Related]

  • 17. The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
    Krapf JM, Simon JA.
    Maturitas; 2009 Jul 20; 63(3):213-9. PubMed ID: 19487090
    [Abstract] [Full Text] [Related]

  • 18. Clinically relevant changes in sexual desire, satisfying sexual activity and personal distress as measured by the profile of female sexual function, sexual activity log, and personal distress scale in postmenopausal women with hypoactive sexual desire disorder.
    DeRogatis LR, Graziottin A, Bitzer J, Schmitt S, Koochaki PE, Rodenberg C.
    J Sex Med; 2009 Jan 20; 6(1):175-83. PubMed ID: 19170847
    [Abstract] [Full Text] [Related]

  • 19. Flibanserin.
    Vallejos X, Wu C.
    J Pharm Pract; 2017 Apr 20; 30(2):256-260. PubMed ID: 26873507
    [Abstract] [Full Text] [Related]

  • 20. Outcome measurement in female sexual dysfunction clinical trials: review and recommendations.
    Althof SE, Rosen RC, DeRogatis L, Corty E, Quirk F, Symonds T.
    J Sex Marital Ther; 2005 Apr 20; 31(2):153-66. PubMed ID: 15859374
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.